In addition, some features have been investigated in the context of glioblastoma, in particular assessing the morphology of noncontrast-enhancing tumor as a predictor of IDH status [7, 13], but these have not yet been investigated in the context of LGG to our knowledge. The gene discussed is IDH1; the disease is glioblastoma.